Style 10 (Orange) - Menu by Apycom.com

 
Home » Education

 

EDUCATION


7/2004 - 5/2006

M.S.
Master of Science in Clinical Research
Mount Sinai School of Medicine

7/2000 - 6/2004

Resident Physician
Department of Radiation Oncology
Mount Sinai School of Medicine, New York, New York

  • Chief Resident 2003 – 2004

7/1995 - 6/1999 M.D.
School of Medicine
State University of New York at Stony Brook, Stony Brook, New York

7/1993 - 6/1995 Post-baccalaureate Pre-med Program
School of General Studies
Columbia University, New York, New York

7/1989 - 6/1993

B.A., History
Columbia College
Columbia University, New York, New York

  • John Jacob Astor Scholar, 1989 - 1993

 

Connect
                                                   with Dr. Cesaretti

Schedule a Consultation
Request a Free Book
PSA Facts

RESEARCH EXPERIENCE

7/1993 - 6/1995

Research Assistant
Department of Pathology, College of Physicians & Surgeons
Columbia University, New York, New York

  • Lab focus on study of neuronal cytoskeleton and plaque-associated disease states.



GRANTS

Sponsor: Department of the Army, Prostate Cancer Research Program PC07201
Project entitled, ”Genome-Wide Association Study to Identify SNPs and CNPs Associated with Development of Radiation Injury in Prostate Cancer Patients Treated with Radiotherapy.”

Sponsor: National Institute of Health Loan Repayment Program
Project entitled, ”ATM Heterozygosity and the Development of Radiation-Induced Erectile Dysfunction and Urinary Morbidity Following Radiotherapy for Prostate Cancer.”

Sponsor: American Cancer Society
Project entitled, ”Genetic Predictors of Adverse Radiotherapy Response in African-Americans.”

Basic Science Travel Grant, Cesaretti JA
ASTRO Research Evaluation Committee
ASTRO's 46th Annual Meeting in Atlanta, GA from October 3-7, 2004

Physician Research Training Award, PCO31163, 2003,
Prostate Cancer Research Program.
Sponsor:  Department of Defense.
Project entitled, “ATM Heterozygosity and the Development of Radiation-Induced Erectile Dysfunction and Urinary Morbidity Following Radiotherapy for Prostate Cancer.”

 


This site uses cookies to improve your experience and analyze site traffic. You can accept or opt out of non-essential cookies below. See our Privacy Policy & Terms for details.